| 40.55 Data as of 9:35am ET | -0.10 / -0.25%Today’s Change | 29.50 Today|||52-Week Range 40.94 | +24.50% Year-to-Date |
The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the StrataQuant(R) Health Care Index. The fund will normally invest at least 90% of its net assets in common stocks that comprise the index. The index is a modified equal-dollar weighted index designed by NYSE Euronext to objectively identify and select stocks from the Russell 1000(R) Index in the health care sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX(R) selection methodology. It is non-diversified.
| 1 month | +0.79% | 3 years | +21.17% | |
| 3 months | +9.40% | 5 years | +17.83% | |
| 1 year | +34.15% | Since inception | +12.41% |
| Previous close | $40.65 |
| Open day’s range | 40.55 – 40.77 |
| Net asset value (NAV) | 40.62 (06/18/2013) |
| Daily volume | 2,419 |
| Average volume (3 months) | 150,054 |
| FXH | Category | |
|---|---|---|
| Performance 5-yr return | +17.83% | +13.03% |
| Expense Gross exp ratio | 0.73% | 0.47% |
| Risk 5 year sharpe ratio | 0.92 | 0.76 |
| Net assets | $872.1M | $762.0M |
| Average market cap | $12.9B | $19.5B |
| Average P/E | 18.6 | 21.7 |
| Dividend / Share | -- | 0.22% |
| VHT Vanguard Health Care ETF |
| XLV Health Care Select Sector SPDR Fund |
| IXJ iShares S&P Global Healthcare Index Fund |
| Healthcare | 95.34% |
| Hardware | 1.36% |
| Business service | 0.47% |
| Telecommunication | 0.44% |
| Consumer goods | 0.00% |
| WLP WellPoint Inc | 2.51% |
| BMRN Biomarin Pharmaceutical, Inc. | 2.47% |
| GILD Gilead Sciences Inc | 2.45% |
| ABC AmerisourceBergen Corp | 2.43% |
| ABT Abbott Laboratories | 2.43% |
| UHS Universal Health Services, Inc. Class B | 2.38% |
| UNH UnitedHealth Group Inc | 2.36% |
| CVD Covance, Inc. | 2.36% |
| CELG Celgene Corporation | 2.34% |
| LPNT LifePoint Hospitals, Inc. | 2.31% |